Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function

Journal of General Virology

Volumn 95, Issue PART 6, 2014, Pages 1366-1375

  Heilingloh, Christiane S ^a   Mühl Zürbes, Petra ^a   Steinkasserer, Alexander ^a   Kummer, Mirko ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4[4 (5 NITROFURAN 2 YLMETHYLENE) 3.5 DIOXO PYRAZOLIDIN 1 YL] BENZOIC ACID ETHYL ESTER; CD83 ANTIGEN; IMMEDIATE EARLY PROTEIN; INFECTED CELL PROTEIN 0; LIGASE INHIBITOR; LYSINE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; ENZYME ACTIVITY; ENZYME DEGRADATION; HEK293 CELL LINE; HERPES SIMPLEX; HUMAN; HUMAN CELL; MATURE DENDRITIC CELL; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ANTIGENS, CD; DENDRITIC CELLS; GENES, VIRAL; HEK293 CELLS; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNE EVASION; IMMUNOGLOBULINS; LYSINE; MEMBRANE GLYCOPROTEINS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84900865090     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.062810-0     Document Type: Article

References (51)

1. Aerts-Toegaert, C., Heirman, C., Tuyaerts, S., Corthals, J., Aerts, J. L., Bonehill, A., Thielemans, K. & Breckpot, K. (2007). CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37, 686-695.
2. Anandasabapathy, N., Ford, G. S., Bloom, D., Holness, C., Paragas, V., Seroogy, C., Skrenta, H., Hollenhorst, M., Fathman, C. G. & Soares, L. (2003). GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18, 535-547.
3. Banchereau, J. & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
4. Bock, F., Rössner, S., Onderka, J., Lechmann, M., Pallotta, M. T., Fallarino, F., Boon, L., Nicolette, C., DeBenedette, M. A. & other authors (2013). Topical application of soluble CD83 induces IDOmediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival. J Immunol 191, 1965-1975.
5. Boutell, C., Sadis, S. & Everett, R. D. (2002). Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76, 841-850.
6. Breitschopf, K., Bengal, E., Ziv, T., Admon, A. & Ciechanover, A. (1998). A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J 17, 5964-5973.
7. Coffin, R. S., MacLean, A. R., Latchman, D. S. & Brown, S. M. (1996). Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther 3, 886-891.
8. Erales, J. & Coffino, P. (2014). Ubiquitin-independent proteasomal degradation. Biochim Biophys Acta 1843, 216-221.
9. Everett, R. D. (2000). ICP0, a regulator of herpes simplex virus during lytic and latent infection. BioEssays 22, 761-770.
10. Everett, R. D., Preston, C. M. & Stow, N. D. (1991). Functional and genetic analysis of the role of Vmw110 in herpes simplex virus replication, pp. 50-76. In Herpes Virus Transcription and its Regulation. Edited by E. K. Wagner. Boca Raton, FL: CRC Press.
11. Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. & Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110-and proteasomedependent loss of several PML isoforms. J Virol 72, 6581-6591.
12. Everett, R. D., Boutell, C. & Orr, A. (2004). Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0. J Virol 78, 1763-1774.
13. Everett, R. D., Rechter, S., Papior, P., Tavalai, N., Stamminger, T. & Orr, A. (2006). PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80, 7995-8005.
14. Fujimoto, Y., Tu, L., Miller, A. S., Bock, C., Fujimoto, M., Doyle, C., Steeber, D. A. & Tedder, T. F. (2002). CD83 expression influences CD4+ T cell development in the thymus. Cell 108, 755-767.
15. Ge, W., Arp, J., Lian, D., Liu, W., Baroja, M. L., Jiang, J., Ramcharran, S., Eldeen, F. Z., Zinser, E. & other authors (2010). Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection. Transplantation 90, 1145-1156.
16. Glickman, M. H. & Ciechanover, A. (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82, 373-428.
17. Gu, H. & Roizman, B. (2003). The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci U S A 100, 8963-8968.
18. Hagglund, R. & Roizman, B. (2004). Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol 78, 2169-2178.
19. Hock, B. D., Kato, M., McKenzie, J. L. & Hart, D. N. (2001). A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. Int Immunol 13, 959-967.
20. Hock, B. D., Haring, L. F., Steinkasserer, A., Taylor, K. G., Patton, W. N. & McKenzie, J. L. (2004). The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. Leuk Res 28, 237-241.
21. Hwang, J. & Kalejta, R. F. (2007). Proteasome-dependent, ubiquitinindependent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367, 334-338.
22. Kalejta, R. F. & Shenk, T. (2003). Proteasome-dependent, ubiquitinindependent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci U S A 100, 3263-3268.
23. Klein, E., Koch, S., Borm, B., Neumann, J., Herzog, V., Koch, N. & Bieber, T. (2005). CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int Immunol 17, 477-487.
24. Kruse, M., Rosorius, O., Krätzer, F., Stelz, G., Kuhnt, C., Schuler, G., Hauber, J. & Steinkasserer, A. (2000). Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 74, 7127-7136.
25. Kummer, M., Turza, N. M., Muhl-Zurbes, P., Lechmann, M., Boutell, C., Coffin, R. S., Everett, R. D., Steinkasserer, A. & Prechtel, A. T. (2007). Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome. J Virol 81, 6326-6338.
26. Lan, Z., Lian, D., Liu, W., Arp, J., Charlton, B., Ge, W., Brand, S., Healey, D., DeBenedette, M. & other authors (2010). Prevention of chronic renal allograft rejection by soluble CD83. Transplantation 90, 1278-1285.
27. Lees-Miller, S. P., Long, M. C., Kilvert, M. A., Lam, V., Rice, S. A. & Spencer, C. A. (1996). Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J Virol 70, 7471-7477.
28. Lomonte, P. & Everett, R. D. (1999). Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G1 into S phase of the cell cycle. J Virol 73, 9456-9467.
29. Lomonte, P., Sullivan, K. F. & Everett, R. D. (2001). Degradation of nucleosome-associated centromeric histone H3-like protein CENP-A induced by herpes simplex virus type 1 protein ICP0. J Biol Chem 276, 5829-5835.
30. Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S. & Weissman, A. M. (1999). RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A 96, 11364-11369.
31. Maul, G. G. & Everett, R. D. (1994). The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 75, 1223-1233.
32. Morrow, G., Slobedman, B., Cunningham, A. L. & Abendroth, A. (2003). Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. J Virol 77, 4950-4959.
33. Parkinson, J., Lees-Miller, S. P. & Everett, R. D. (1999). Herpes simplex virus type 1 immediate-early protein Vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNAdependent protein kinase. J Virol 73, 650-657.
34. Prechtel, A. T., Turza, N. M., Theodoridis, A. A. & Steinkasserer, A. (2007). CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178, 5454-5464.
35. Reinwald, S., Wiethe, C., Westendorf, A. M., Breloer, M., Probst-Kepper, M., Fleischer, B., Steinkasserer, A., Buer, J. & Hansen, W. (2008). CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J Immunol 180, 5890-5897.
36. Samady, L., Costigliola, E., MacCormac, L., McGrath, Y., Cleverley, S., Lilley, C. E., Smith, J., Latchman, D. S., Chain, B. & Coffin, R. S. (2003). Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs2 HSV vectors for dendritic cell-mediated immunotherapy. J Virol 77, 3768-3776.
37. Schmidtke, G., Aichem, A. & Groettrup, M. (2014). FAT10ylation as a signal for proteasomal degradation. Biochim Biophys Acta 1843, 97-102.
38. Sdek, P., Ying, H., Chang, D. L. F., Qiu, W., Zheng, H., Touitou, R., Allday, M. J. & Xiao, Z.-X. (2005). MDM2 promotes proteasomedependent ubiquitin-independent degradation of retinoblastoma protein. Mol Cell 20, 699-708.
39. Sénéchal, B., Boruchov, A. M., Reagan, J. L., Hart, D. N. & Young, J. W. (2004). Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103, 4207-4215.
40. Setz, C., Friedrich, M., Hahn, S., Dörrie, J., Schaft, N., Schuler, G. & Schubert, U. (2013). Just one position-independent lysine residue can direct MelanA into proteasomal degradation following N-terminal fusion of ubiquitin. PLoS ONE 8, e55567.
41. Singh Gautam, A. K., Balakrishnan, S. & Venkatraman, P. (2012). Direct ubiquitin independent recognition and degradation of a folded protein by the eukaryotic proteasomes-origin of intrinsic degradation signals. PLoS ONE 7, e34864.
42. Sodeik, B., Ebersold, M. W. & Helenius, A. (1997). Microtubulemediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J Cell Biol 136, 1007-1021.
43. Su, L. L., Iwai, H., Lin, J. T. & Fathman, C.G. (2009). The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells. J Immunol 183, 438-444.
44. Uhde, M., Kuehl, S., Richardt, U., Fleischer, B. & Osterloh, A. (2013). Differential regulation of marginal zone and follicular B cell responses by CD83. Int Immunol 25, 507-520.
45. Van Sant, C., Hagglund, R., Lopez, P. & Roizman, B. (2001). The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitinconjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 98, 8815-8820.
46. Whitley, R. J. & Roizman, B. (2001). Herpes simplex virus infections. Lancet 357, 1513-1518.
47. Winkler, L. L., Hwang, J. & Kalejta, R. F. (2013). Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle. J Virol 87, 4665-4671.
48. Wolenski, M., Cramer, S. O., Ehrlich, S., Steeg, C., Fleischer, B. & von Bonin, A. (2003). Enhanced activation of CD83-positive T cells. Scand J Immunol 58, 306-311.
49. Yang, Y., Kitagaki, J., Dai, R. M., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V. & other authors (2007). Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res 67, 9472-9481.
50. Zhou, L. J. & Tedder, T. F. (1996). CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A 93, 2588-2592.
51. Zinser, E., Lechmann, M., Golka, A., Lutz, M. B. & Steinkasserer, A. (2004). Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J Exp Med 200, 345-351.